Aethlon Medical (AEMD) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aethlon Medical is the larger company by market cap ($9.7 million vs $6.6 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEMD | VNRX |
|---|---|---|
| Share price | $6.03 | $0.2201 |
| Market cap | $9.67M | $6.62M |
| 1-day change | +0.33% | +0.32% |
| EPS (TTM) | $-32.97 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.00 | $10.40 |
| 52-week low | $1.41 | $0.22 |
| Distance from 52-week high | -83.70% | -97.88% |
| Analyst consensus | none | none |
| Avg. price target upside | +119.73% | +6088.10% |
| Average volume | 2.56M | 8.47M |
| Shares outstanding | 1.60M | 30.06M |
| Employees | 9 | 57 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aethlon Medical
AEMD stock →Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.
Health Care · Medical/Dental Instruments · 9 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
AEMD vs VNRX FAQ
Which is bigger, Aethlon Medical or VolitionRX?
Aethlon Medical (AEMD) is larger, with a market capitalization of $9.67M compared with $6.62M for VolitionRX (VNRX).
Are Aethlon Medical and VolitionRX in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Aethlon Medical and Biotechnology: In Vitro & In Vivo Diagnostic Substances for VolitionRX.